Studies investigating the effectiveness of an intervention or treatment often require long term follow-up of patients Availability of a surrogate marker would potentially allow researchers to make conclusions regarding the treatment effect with less required follow-up time and/or less cost Could enable shorter randomized clinical trials and require smaller sample sizes ? accelerate acquisition of clinical information